COMMODORE CAPITAL LP – Celldex Therapeutics, Inc. Transaction History
COMMODORE CAPITAL LP portfolio value:
$15.14M
portfolio value
COMMODORE CAPITAL LP quarter portfolio value change:
+4.27%
quarter
Celldex Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 620K | $28.11 | 538.81K | |
| Q2 2022 | share | Increase | +123.39% | 297.61K shares | 6.31M | $26.96 | 538.81K |
| Q1 2022 | share | Increase | 0.00% | 241.19K shares | 8.21M | $34.06 | 241.19K |
| Q4 2021 | share | Decrease | -100.00% | -248.20K shares | -13.40M | $38.9 | 0 |
| Q3 2021 | share | Decrease | -23.26% | -75.23K shares | 2.58M | $53.99 | 248.20K |
| Q2 2021 | share | Decrease | -12.57% | -46.51K shares | 3.19M | $33.44 | 323.43K |
| Q1 2021 | share | Increase | +3.79% | 13.52K shares | 1.37M | $20.6 | 369.95K |
| Q4 2020 | share | Increase | 0.00% | 356.43K shares | 6.24M | $17.52 | 356.43K |